Medicxi Ventures Management (Jersey) LTD Aura Biosciences, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $481 Million
- Q3 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 3,039,892 shares of AURA stock, worth $23.1 Million. This represents 5.63% of its overall portfolio holdings.
Number of Shares
3,039,892
Previous 3,039,892
-0.0%
Holding current value
$23.1 Million
Previous $23 Million
17.86%
% of portfolio
5.63%
Previous 8.2%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$52.6 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$44.1 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$37.1 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$22.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$13.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $222M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...